Mustafa KULAKSIZOĞLU, Elif TURAN, Feridun KARAKURT, Ahmet KAYA

Metabolic Parameters in Patients with Adrenal Insidentaloma

ABSTRACT Aim: Our aim is to determine the metabolic state in patients with incidental adrenal mass. Material and Methods: 67 patients in whom functional tests about adrenal incidental mass were assessed in University of Necmettin Erbakan, Faculty of Medicine, Department of Endocrinology and Metabolism, were admitted to the study. Results: Of these 67 patients, 34 were male and 33 were female. Mean age was 57.1±12, mean body mass index was 29.1±6 kg/m2. In patients enrolled to the study; cushing s syndrome, pheochromocytoma, primary hyperaldosteronism tests were performed. Functional adrenal mass was detected in 8 patients (6 pheochromocytoma, 1 cushing s syndrome, 1 primary hyperaldosteronism). Impaired fasting glucose or type 2 diabetes were identified in 38 patients. Mean glucose was 127.6±18 mg/dL in all patients. Mean glucose in patients with functional and non-functional mass were 117.2±32 mg/dL and 129±62 mg/dL respectively. Mean systolic blood pressure was 125±18 mmHg, and diastolic blood pressure was 77±10.9 mmHg in all patients. Mean systolic pressure was 135±10.4 mmHg in patients with functional mass and 124±19 mmHg in patients with non-functional mass. Mean triglyceride was 157.5 ± 83 mg/dL (normal

PDF

___

1. Carrol TB, Aron DC, Findling JW, Tyrell JB. Glukokortikoidler ve adrenal androjenler, Greenspantemal Ve Klinik Endokrinoloji, çev ed:Tütüncü NB, Güneş Kitabevi, Ankara.2013; 285-328.
2. Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T. The improvement of insulin resistance in patients with adrenal incidentalomas by surgical resection. Clinical Endocrinology. 2001;54(6):797804.
3. Emral R, Uysal AR, Asik M, Gullu S, Corapcioglu D, Tonyukuk V et al. Prevalence of subclinical Cushings syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes. Endocrine Journal. 2003.;50(4):399-408.
4. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B et al. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology. 2003;148(2): 213219.
5. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K. nonfunctionWorld J Surg Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushings syndrome. Endocrine Journal. 2008;55(4):737745.
6. Chiodini I, Morelli V, Salcuni AS, Eller Vainicher C, Torlontano M, Coletti F et al. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. Journal of Clinical Endocrinology and Metabolism. 2010;95(6):2736 2645.
7. Mantero F, Terzolo M, Arnaldi G, et al. A Survey on Adrenal Incidentaloma in Italy. J Clin Endocrinol Metab. 2000;85(2): 637-644
8. Terzolo M, Pia A, Ali A, et al. Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome. J Clin Endocrinol Metab. 2002;87(3): 998-1003
9. Tauchmanova L, Rossi R, Biondi B, et al. Patients with subclinical Cushings syndrome due to adrenal adenoma have increased cardiovasculer risk. J Clin Endocrinol Metab. 2002;87(11):4872-4878
10. Muscogiuri G1, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? Clin Endocrinol (Oxf). 2011;74(3):300-5.
11. Erbil Y, Ozbey N, Barbaros U, Unalp HR, Salmaslioglu A, Ozarmagan S. Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality? World J Surg. 2009;33(10):2099-105.